Results 41 to 50 of about 512 (124)

Dulaglutide treatment reverses depression‐like behavior and hippocampal metabolomic homeostasis in mice exposed to chronic mild stress

open access: yesBrain and Behavior, Volume 14, Issue 3, March 2024.
In this article, the antidepressant effects of dulaglutide in a CMS depression model were confirmed. We identified a total of 20 differentially metabolites between the CON and CMS+Veh groups and 46 metabolites between the CMS+Veh and High Dula groups in the hippocampus of mice.
Man Jin   +10 more
wiley   +1 more source

Production of 2,5‐Furandicarboxylic Acid Methyl Esters from Pectin‐Based Aldaric Acid: from Laboratory to Bench Scale

open access: yesChemSusChem, Volume 17, Issue 1, January 8, 2024.
The synthesis and purification of pectin‐based 2,5‐furandicarboxylic acid methyl esters from gram‐scale to kilogram‐scale enables the valorisation of agricultural side streams into fully renewable polyesters. Abstract 2,5‐Furandicarboxylic acid (FDCA) is one of the most attractive emerging renewable monomers, which has gained interest especially in ...
Nicolaas van Strien   +4 more
wiley   +1 more source

Isolation of D-Galactaric Acid and Isocitric Acid from Ferocactus acanthodes Br. et R.. [PDF]

open access: yesActa Chemica Scandinavica, 1973
Randi Kringstad   +5 more
openaire   +2 more sources

(2S, 3R, 4S, 5R) -2,3,4,5-TETRAHYDROXYHEXANEDIOIC (GALACTARIC) ACID: STRUCTURAL FEATURES, ISOMERS, COMPLEXING PROPERTIES

open access: yesOdesa National University Herald. Chemistry, 2015
A review article describes the features of structure and properties of galactaric acid (H6Gala) as a representative of polyhydroxydicarboxylic acids, which is widely used in analytical chemistry, medicine and agriculture. Galactaric acid (mucic acid) has an unusually low solubility in water for an unsubstituted carbohydrate.
openaire   +3 more sources

Serum metabolomics reveals distinctive signature of cancer staging in oral squamous cell carcinoma. [PDF]

open access: yesBMC Oral Health
Lu W   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy